Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0.00%5.6K | 0.00%5.6K | ||||
| Gross profit | 0 | 0 | 0 | 0 | 0.00%-5.6K | 0.00%-5.6K | ||||
| Operating expense | 250.90%1.19M | 40.10%177.46K | 34.22%100.37K | 233.10%269.8K | 838.54%645.53K | -8.42%339.38K | 33.53%126.67K | -24.61%74.78K | 0.00%81K | -28.02%68.78K |
| Selling and administrative expenses | 263.30%1.14M | 46.21%163.88K | 22.46%89.69K | 237.04%256.97K | 871.97%633.75K | -5.84%314.34K | 45.52%112.09K | -22.22%73.24K | 0.00%76.24K | -24.54%65.2K |
| -General and administrative expense | 263.30%1.14M | 46.21%163.88K | 22.46%89.69K | 237.04%256.97K | 871.97%633.75K | -5.84%314.34K | 45.52%112.09K | -22.22%73.24K | 0.00%76.24K | -24.54%65.2K |
| Other operating expenses | 95.32%48.92K | -6.90%13.58K | 592.09%10.68K | 169.87%12.84K | 229.21%11.78K | -31.90%25.05K | -18.25%14.58K | -69.30%1.54K | 0.00%4.76K | -60.92%3.58K |
| Operating profit | -250.90%-1.19M | -40.10%-177.46K | -24.87%-100.37K | -211.58%-269.8K | -838.54%-645.53K | 13.64%-339.38K | -26.09%-126.67K | 23.29%-80.38K | 0.00%-86.59K | 32.00%-68.78K |
| Net non-operating interest income (expenses) | -3.45K | -775 | -1.56K | -4.07%-639 | -478 | 0 | 0 | 0 | 0.00%-614 | 0 |
| Non-operating interest expense | --3.45K | --775 | --1.56K | 4.07%639 | --478 | --0 | --0 | --0 | 0.00%614 | --0 |
| Other net income (expenses) | -162.89%-37.43K | 105.31%59.51K | 97.82%-24.72K | 0.00%5.73K | 47.84K | |||||
| Special income (charges) | -1,025.61%-278.22K | ---- | ---- | ---- | ---- | 97.82%-24.72K | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | 1,025.61%278.22K | ---- | ---- | ---- | ---- | -97.82%24.72K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 185.89%240.79K | ---- | ---- | ---- | ---- | 433.91%84.23K | --0 | ---- | 0.00%5.73K | --47.84K |
| Income before tax | -340.12%-1.23M | -42.46%-215.66K | -26.82%-101.93K | -231.93%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 18.13%-80.38K | 0.00%-81.48K | 79.42%-20.94K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -340.12%-1.23M | -42.46%-215.66K | -26.82%-101.93K | -231.93%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 18.13%-80.38K | 0.00%-81.48K | 79.42%-20.94K |
| Net income continuous operations | -340.12%-1.23M | -42.46%-215.66K | -26.82%-101.93K | -231.93%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 18.13%-80.38K | 0.00%-81.48K | 79.42%-20.94K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -340.12%-1.23M | -40.97%-213.41K | -36.31%-101.93K | -231.93%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 23.83%-74.78K | 0.00%-81.48K | 79.42%-20.94K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -340.12%-1.23M | -40.97%-213.41K | -36.31%-101.93K | -231.93%-270.44K | -2,984.89%-646.01K | 81.54%-279.88K | 87.73%-151.39K | 23.83%-74.78K | 0.00%-81.48K | 79.42%-20.94K |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0 | 0 | -6,656.76%-0.01 | 0.00%-0.01 | -28.52%-0.01 | 0 | 0 | 82.17%-0.0001 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0 | 0 | -6,656.76%-0.01 | 0.00%-0.01 | -27.75%-0.01 | 0 | 0 | 82.17%-0.0001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.